DOI: 10.1158/2159-8290.cd-26-1179 ISSN: 2159-8274
Targeting RAS for Pancreatic Cancer Interception
Sandra Misale, Neeha Zaidi, Elizabeth M. Jaffee, Alison P. Klein, Laura D. WoodSummary:
Multiple strategies to target RAS are now available to treat pancreatic cancer. As pancreatic precancers also have KRAS mutations, these tools hold great promise for cancer interception.